792970-10-6Relevant articles and documents
ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE
-
Page/Page column 32; 37-38, (2008/06/13)
The invention comprises (1) anhydrous crystalline forms of N-[1 -(2-ethoxyethyl)-5-(N- ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3- carbonyl]methanesulfonamide, (2) pharmaceutical compositions comprising at least one such form, (3) methods for the treatment of a phosphodiesterase-5-mediated condition using at least one such form, and (4) methods for preparing such forms.
PYRAZOLO`4,3-D! PYRIMIDINES
-
Page/Page column 105, (2008/06/13)
This invention relates to compounds of formula (I).
5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION
-
Page 202, (2008/06/13)
This invention relates to compounds of formula (I).